Evidence map›Paper›PMID 31156634›Full record

ReviewFrontiers in immunology2019

HLA-Class II Artificial Antigen Presenting Cells in CD4

Alexandre Couture, Anthony Garnier, Fabian Docagne, Olivier Boyer, Denis Vivien, Brigitte Le-Mauff, Jean-Baptiste Latouche, Olivier Toutirais

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. CD4Frontiers in immunology · 2025
    Review
  16. Review
  17. Langerhans Cells Directly Interact with Resident T Cells in the Human Epidermis.JID innovations : skin science from molecules to population health · 2025
    Article
  18. Article
  19. Article
  20. Establishment of an in vitro evaluation method for immunomodulatory functions of yeast strains.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexandre CoutureUNIROUEN, Inserm U1245, Institute for Research and Innovation in Biomedicine, Normandie University, Rouen, France.
Anthony GarnierInserm U1237, Physiopathology and Imaging of Neurological Disorders, Caen University Hospital, Caen, France.
Fabian DocagneInserm U1237, Physiopathology and Imaging of Neurological Disorders, Caen University Hospital, Caen, France.
Olivier BoyerDepartment of Immunology and Biotherapy, Inserm U1234, Institute for Research and Innovation in Biomedicine, UNIROUEN, Rouen University Hospital, Normandie University, Rouen, France.
Denis VivienInserm U1237, Physiopathology and Imaging of Neurological Disorders, Caen University Hospital, Caen, France.
Brigitte Le-MauffInserm U1237, Physiopathology and Imaging of Neurological Disorders, Caen University Hospital, Caen, France.
Jean-Baptiste LatoucheUNIROUEN, Inserm U1245, Institute for Research and Innovation in Biomedicine, Normandie University, Rouen, France.
Olivier ToutiraisInserm U1237, Physiopathology and Imaging of Neurological Disorders, Caen University Hospital, Caen, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD4

Indexed as

Antigen PresentationAntigen-Presenting CellsCancer VaccinesCD4-Positive T-LymphocytesCell ProliferationHistocompatibility Antigens Class IIHLA AntigensHumansImmunotherapy, AdoptiveT-Lymphocytes, RegulatoryCancer VaccinesHistocompatibility Antigens Class IIHLA Antigensadoptive cell therapyartificial antigen presenting cellsautoimmunitycancerCD4+ T lymphocytesHLA class II molecules

Identifiers

PMID31156634
PMCPMC6533590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.